Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
48 studies found for:    Open Studies | "Water-Electrolyte Imbalance"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Water-Electrolyte Imbalance"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Postoperative Hyponatremia - Are There Gender Differences?
Condition: Hyponatremia
Interventions: Procedure: Fluid administration;   Procedure: Perioperative fluid management based on Lean Body Mass
2 Not yet recruiting Hylenex-Assisted Resuscitation in Kenya (HARK) Trial for the Management of Dehydration
Condition: Dehydration
Interventions: Drug: Hyaluronic Acid;   Drug: control
3 Recruiting Phase II Pre-operative Vitamin D Supplementation to Prevent Post-thyroidectomy Hypocalcemia
Conditions: Thyroid Nodules;   Hypocalcemia
Interventions: Dietary Supplement: Calcitriol;   Dietary Supplement: Control Pill
4 Recruiting Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D
Conditions: Primary Hyperparathyroidism;   Hypercalcemia;   Vitamin D Deficiency;   Osteoporosis;   Osteopenia
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Vitamin D3
5 Unknown  Frequency and Origin of Dysnatremias in the Emergency Department
Conditions: Hyponatremia;   Hypernatremia
Intervention:
6 Not yet recruiting An Extension Follow-up Trial to Evaluate the Long-term Safety of Children and Adolescent Subjects With Euvolemic or Hypervolemic Hyponatremia
Condition: Hyponatremia
Intervention: Drug: Tolvaptan
7 Recruiting A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Condition: Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Intervention: Drug: tolvaptan
8 Recruiting Comparison of Enteral Versus Intravenous Potassium Supplementation
Condition: Acute Hypokalemia
Interventions: Drug: Intravenous potassium chloride;   Drug: Oral potassium chloride
9 Unknown  The Effect of Fluid Restriction in Congestive Heart Failure Complicated With Hyponatremia
Conditions: Heart Failure;   Hyponatremia
Intervention: Other: Fluid restriction
10 Unknown  Pseudohyponatremia of Multiple Myeloma is True Hyponatremia
Condition: Hyponatremia of Multiple Myeloma
Intervention: Other: blood test
11 Recruiting Institutional Registry of Hyponatremia
Condition: Hyponatremia
Intervention:
12 Recruiting A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium Concentrations
Condition: Autosomal Dominant Hypocalcemia (ADH)
Intervention: Drug: NPSP795
13 Recruiting Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia
Condition: Hyponatremia
Intervention: Drug: Tolvaptan
14 Not yet recruiting The Clinical and Laboratory Characteristics of Recurrent Drug- Related Hyponatremia
Conditions: Hyponatremia;   SIADH
Intervention:
15 Unknown  Radiocontrast Media Induced Hyponatremia
Condition: Percutaneous Coronary Intervention
Intervention:
16 Not yet recruiting ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study
Conditions: Sarcoidosis;   Hypercalcemia Due to Sarcoidosis
Intervention: Drug: ACTHAR Gel (adrenocorticotropic hormone)
17 Unknown  Tolvaptan for Hyponatremia in Cirrhotic Patients With Ascites
Conditions: Hyponatremia;   Ascites
Interventions: Drug: Tolvaptan;   Drug: placebo
18 Recruiting Hyponatremia and Myometrium Contractility. An Invitro Study
Condition: Hyponatremia
Intervention:
19 Recruiting Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia
Condition: Hyponatremia
Interventions: Drug: Tolvaptan;   Drug: Placebo;   Behavioral: Hepatic Encephalopathy Assessment;   Behavioral: Quality of Life Assessment;   Biological: Vital signs;   Biological: Blood laboratory tests;   Procedure: Ascites Evaluation;   Procedure: Edema
20 Unknown  Parathyroid Hormone (PTH) Homeostasis in Bartter Syndrome
Conditions: Hypocalcemia;   Hypercalcemia
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years